Mustang Bio (MBIO) Enterprise Value (2017 - 2026)

Mustang Bio (MBIO) has reported Enterprise Value for 10 consecutive years, with -$10.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 12.24% year-over-year to -$10.5 million in Q2 2026; TTM through Jun 2026 was -$10.5 million, a 12.24% decrease from a year earlier, with the FY2025 full-year figure at -$12.5 million, down 763.09% from the prior year.
• Enterprise Value was -$10.5 million for Q2 2026 at Mustang Bio, up from -$11.4 million in the prior quarter.
• Over five years, Enterprise Value peaked at $4.9 billion in Q1 2022 and troughed at -$12.5 million in Q4 2025.
• A 5-year average of $1.1 billion and a median of $518.8 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value slumped 763.09% in 2025 and declined 6.86% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at $2.0 billion in 2022, then slumped by 72.43% to $559.1 million in 2023, then slumped by 100.26% to -$1.4 million in 2024, then tumbled by 763.09% to -$12.5 million in 2025, then climbed by 15.8% to -$10.5 million in 2026.
• The last three Enterprise Value figures came in at -$10.5 million (Q2 2026), -$11.4 million (Q1 2026), and -$12.5 million (Q4 2025), per Business Quant data.